Find Clinical Trials by University in Canada

Paid Clinical Trials and Focus Groups



Find Paid Clinical Trials

Paid Clinical Trials - : Canada




  • Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene Foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Conditions:   Breast Cancer;   Heart Failure
    Intervention:   Drug: perindopril (or placebo) OR bisoprolol (or placebo) OR both perindopril and bisoprolol OR placebo
    Sponsor:   University of Alberta
    Not yet recruiting - verified November 2009

  • Conditions:   Lymphoma;   Multiple Myeloma;   Influenza A Virus, H1N1 Subtype
    Intervention:   Biological: AS03-adjuvanted H1N1 pandemic influenza vaccine
    Sponsors:   University Health Network, Toronto;   Princess Margaret Hospital, Canada
    Recruiting - verified November 2009

  • Conditions:   Cigarette Smoking;   Nicotine Addiction;   Smoking Cessation
    Interventions:   Drug: bupropion HCl;   Behavioral: smoking cessation counselling
    Sponsors:   Centre for Addiction and Mental Health;   Ontario Ministry of Health Promotion
    Recruiting - verified November 2009

  • Condition:   Peptic Ulcer Disease
    Interventions:   Drug: Esomeprazole/ASA Fixed Combination;   Drug: Esomeprazole;   Drug: ASA
    Sponsor:   AstraZeneca
    Not yet recruiting - verified November 2009

  • Condition:   Ulcerative Proctitis
    Interventions:   Procedure: Proctosigmoidoscopy or colonoscopy with biopsy;   Procedure: Proctosigmoidoscopy;   Procedure: Blood collection;   Procedure: Electrocardiogram (ECG);   Drug: MAX-002;   Drug: Canasa®;   Drug: Placebo
    Sponsor:   Axcan Pharma
    Recruiting - verified November 2009

  • Conditions:   Acute Coronary Syndrome;   Percutaneous Coronary Intervention
    Intervention:   Procedure: Percutaneous Coronary Intervention
    Sponsors:   Population Health Research Institute;   Co-sponsor: Sanofi-Aventis
    Recruiting - verified November 2009

  • Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: insulin glargine;   Drug: Apidra (insulin glulisine)
    Sponsor:   Sanofi-Aventis
    Recruiting - verified November 2009

  • Conditions:   Obesity;   Gastric Bypass
    Intervention:  
    Sponsor:   University of Alberta
    Recruiting - verified November 2009

  • Condition:   Visual Impairment Due to Leber Congenital Amaurosis (LCA)
    Intervention:   Drug: QLT091001
    Sponsor:   QLT Inc
    Recruiting - verified November 2009

  • Conditions:   Renal Cell Carcinoma;   Cardiotoxicity;   Heart Failure;   Hypertension
    Intervention:  
    Sponsor:   University of Alberta
    Not yet recruiting - verified November 2009

  • Condition:   Prostate Cancer
    Intervention:  
    Sponsors:   University Health Network, Toronto;   Princess Margaret Hospital, Canada
    Not yet recruiting - verified November 2009

  • Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: linagliptin;   Drug: placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Condition:   Lung Cancer
    Interventions:   Procedure: Cervical Mediastinoscopy;   Procedure: Endobronchial Ultrasound (EBUS);   Procedure: Endoscopic Ultrasound (EUS)
    Sponsors:   Centre hospitalier de l'Université de Montréal (CHUM);   Fonds de la Recherche en Santé du Québec;   Society of University Surgeons;   Centre de Recherche du CHUM (CRCHUM);   Division de Chirurgie Thoracique du CHUM
    Recruiting - verified November 2009

  • Condition:   Myopia
    Interventions:   Device: lotrafilcon B;   Device: Balafilcon A;   Device: Senofilcon A;   Device: enfilcon A
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Condition:   Infantile Hemangioma
    Intervention:   Drug: Nadolol
    Sponsor:   The Hospital for Sick Children
    Not yet recruiting - verified November 2009

  • Condition:   Lymphocytic Leukemia, Chronic
    Interventions:   Drug: RO5072759;   Drug: rituximab;   Drug: chlorambucil
    Sponsors:   Hoffmann-La Roche;   Genentech
    Not yet recruiting - verified November 2009

  • Condition:   Melanoma
    Interventions:   Drug: YM155;   Drug: Docetaxel
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Condition:   Ankle/Hindfoot Fusion
    Interventions:   Device: Augment™ Injectable;   Procedure: Standard of care
    Sponsor:   BioMimetic Therapeutics
    Recruiting - verified November 2009

  • Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Condition:   Stress Urinary Incontinence Cell Therapy
    Intervention:   Biological: Autologous Muscle Derived Cells
    Sponsor:   Cook
    Not yet recruiting - verified November 2009

  • Condition:   Maraviroc Concentrations in Semen
    Intervention:   Other: Measuring semen samples
    Sponsor:   Canadian Immunodeficiency Research Collaborative
    Recruiting - verified November 2009

  • Condition:   Cardiac Pacemaker, Artificial
    Intervention:  
    Sponsor:   Maisonneuve-Rosemont Hospital
    Recruiting - verified November 2009

  • Condition:   Influenza A Virus H1N1 Subtype
    Intervention:   Drug: Oseltamivir
    Sponsors:   University of Manitoba;   Hoffmann-La Roche
    Not yet recruiting - verified November 2009

  • Condition:   Asthma
    Interventions:   Drug: Azithromycin;   Drug: Placebo
    Sponsor:   Alberta Children's Hospital
    Not yet recruiting - verified November 2009

  • Condition:   Falls
    Intervention:  
    Sponsor:   University of British Columbia
    Not yet recruiting - verified November 2009

  • Condition:   Allergy
    Interventions:   Biological: Toleromune HDM;   Biological: Placebo
    Sponsors:   Circassia Limited;   Adiga Life Sciences
    Not yet recruiting - verified November 2009

  • Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Condition:   Preterm Birth
    Interventions:   Procedure: Transvaginal ultrasound;   Procedure: Vaginal secretion sampling
    Sponsor:   Universitaire de Sherbrooke
    Recruiting - verified November 2009

  • Condition:   Familial or Severe Hypercholesterolemia
    Interventions:   Dietary Supplement: flaxseed;   Dietary Supplement: whole wheat flour
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified November 2009

  • Conditions:   Patellofemoral Syndrome;   Patellofemoral Pain Syndrome;   Anterior Knee Pain Syndrome
    Interventions:   Other: Wii Fit (TM) Interactive Video Game;   Other: Traditional Home Exercise Program
    Sponsor:   University of Manitoba
    Recruiting - verified November 2009

  • Condition:   Patients Undergoing Elective General Anesthesia.
    Interventions:   Procedure: Tracheal intubation;   Procedure: Tracheal intubation
    Sponsor:   Centre hospitalier de l'Université de Montréal (CHUM)
    Not yet recruiting - verified November 2009

  • Condition:   Deep Vein Thrombosis
    Intervention:  
    Sponsors:   Queen's University;   The Physicians' Services Incorporated Foundation
    Not yet recruiting - verified November 2009

  • Condition:   Pediatric Hydrocephalus
    Intervention:  
    Sponsor:   University of Utah
    Recruiting - verified November 2009

  • Conditions:   Pregnancy;   Fertility
    Intervention:  
    Sponsors:   University of Utah;   Department of Health and Human Services
    Recruiting - verified November 2009

  • Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Glycopyrronium bromide;   Drug: Placebo
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Condition:   Pregnancy
    Intervention:   Device: BirthTrack
    Sponsor:   Barnev, Inc.
    Not yet recruiting - verified October 2009

  • Conditions:   Pain;   Anxiety
    Interventions:   Drug: Liposomal lidocaine;   Drug: Vapocoolant spray;   Other: Rubbing adjacent to the injection site;   Other: Distraction
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified October 2009

  • Condition:   Warfarin Dosing
    Intervention:   Other: Algorithm
    Sponsor:   Population Health Research Institute
    Recruiting - verified November 2009

  • Condition:   Ulcerative Colitis
    Interventions:   Drug: Asacol (mesalamine), High Dose;   Drug: Asacol (mesalamine), Low Dose
    Sponsor:   Procter and Gamble
    Recruiting - verified October 2009

  • Condition:   Heart Transplantation
    Intervention:  
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Heart, Lung, and Blood Institute (NHLBI)
    Not yet recruiting - verified October 2009

  • Condition:   Renal Failure
    Intervention:   Device: Paclitaxel eluting balloon
    Sponsor:   University Health Network, Toronto
    Not yet recruiting - verified October 2009

  • Condition:   Diabetic Neuropathy
    Interventions:   Procedure: Nerve Localization in Diabetics Having Foot Surgery under Ultrasound-Guided Ankle Blockade;   Procedure: Nerve Localization in Non-Diabetic Patients Having Foot Surgery Under Ultrasound-Guided Nerve Blockade
    Sponsor:   University Health Network, Toronto
    Not yet recruiting - verified October 2009

  • Condition:   Morbid Obesity
    Interventions:   Other: Patients with a BMI < 30 given Oseltamivir;   Other: Patients with a BMI > 40 given Oseltamivir
    Sponsors:   IWK Health Centre;   Canadian Center for Vaccinology;   Capital District Health Authority;   Dalhousie University;   Hoffmann-La Roche
    Not yet recruiting - verified October 2009

  • Conditions:   HIV Infections;   H1N1 Influenza
    Interventions:   Biological: Arepanrix;   Biological: Arepanrix
    Sponsors:   University of British Columbia;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified October 2009

  • Condition:   Influenza
    Interventions:   Biological: Fluviral influenza vaccine, 2009-2010;   Biological: Normal saline
    Sponsors:   Mount Sinai Hospital, Canada;   GlaxoSmithKline
    Recruiting - verified November 2009

  • Conditions:   Frontotemporal Dementia;   Pick's Disease
    Intervention:   Drug: intranasal oxytocin
    Sponsors:   Lawson Health Research Institute;   Alzheimer's Society London and Middlesex
    Recruiting - verified October 2009
  • Find Paid Clinical Trials